Maynard Um
-
-
-
-
-
-
-
Cytokinetics (CYTK) PT Raised to $110 at Citizens on Strong MYQORZO Launch
-
-
-
-
-
-
-
Cytokinetics launches MYQORZO in Germany, first EU market
-
-
-
-
-
-
-
BofA: Bristol update may boost Cytokinetics shares
-
-
-
-
-
-
-
Stifel on Cytokinetics (CYTK): 'We Think The Trial Likely Works, Positioning Afi As The Best/Only Drug Available For The Entire HCM Spectrum'
-
-
-
-
-
-
-
Cytokinetics (CYTK) Tops Q4 EPS by 6c
-
-
-
-
-
-
-
Cytokinetics (CYTK) PT Raised to $84 at Truist Securities
-
-
-
-
-
-
-
Goldman Sachs Upgrades Cytokinetics (CYTK) to Buy
-
446,440 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

